2018
GNL Celebrates 10th Anniversary (November 2018)
2017
Biodefense Strategy for U.S. Becomes Major Priority; GNL Has Seat at the Policy Table.
2016
UT Chancellor William McRaven Makes National Security, Including Biosecurity, a UT System Priority
2015
GNL’s Expertise in Vector Borne Diseases, including Chikungunya and Zika Play Major Role in International Research
2014
West African Ebola Outbreak Puts GNL and Ebola Research at Forefront of Infectious Disease Attention
2013
Vaccine and Other Medical Countermeasures Are Major Focus at GNL
2010
GNL Begins Increasing Capacity with BSL2, BSL3 and BSL4 Labs all Increasing Research
2008
Galveston National Laboratory Opened
2006
UC7 Galveston National Laboratory Operations
2005
Galveston National Laboratory ground-breaking
2004
Robert E. Shope BSL-4 Laboratory / John Sealy Pavilion opens Institute for Human Infections & Immunity
2003
Western Regional Center of Excellence (RCE)
UC6 Galveston National Laboratory (NBL) awards
NHLBI RSV Proteomics Center
2002
NIAID Hepatitis C Antiviral Contract
Shope BSL-4 Laboratory ground-breaking
Anthrax attacks
2001
UTMB Center for Biodefense
UT System approves BSL-4 lab construction
2000
Sealy Center for Vaccine Development
1997
DARPA Biodefense Grant
WHO Collaborating Center for Arbovirus and HF Virus Research
NIAID Cooperative Hepatitis C Research Center
1995
WHO Collaborating Center for Tropical Diseases World Reference Center for Arboviruses Medical Mycology Reference Center established
1994
Center for Tropical Diseases